You are here: Industry Insights > AIDS

News List

WHO 'Treat All' Recommendation for HIV Widely Implemented drugs
July 25, 2019
The World Health Organization "Treat All" strategy for antiretroviral treatment (ART) initiation among patients living with HIV was the standard of care at...
GSK’s Dovato suppresses AIDS virus at same levels of three-drug regimen expresspharma
July 11, 2019
GlaxoSmithKline Plc’s two-drug HIV regimen Dovato was successful in suppressing the AIDS-causing virus in patients for six months at the same level of a previous three-drug treatment in a late-stage study, the drugmaker said on Wednesday.
For Women With HIV, Daily Life Can Impede Fight Against Virus drugs
May 20, 2019
Day-to-day struggles prevent many American women with HIV from taking medicines to suppress the AIDS-causing virus, a new study shows.
Robotic method isolates high-producing cell lines for HIV vaccine production europeanpharmaceuticalreview
April 29, 2019
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested…
Weekly Infusion May Be Effective, Easier HIV Therapy drugs
April 18, 2019
The advent of highly active antiretroviral therapy (HAART) in the 1990s revolutionized HIV/AIDS treatment.
Laurus Labs enters into strategic partnership agreement with Global Fund expressbpd
March 27, 2019
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic nytimes
March 07, 2019
Scientists have long tried to duplicate the procedure that led to the first long-term remission 12 years ago. With the so-called London patient, they seem to have succeeded.
Global Fund seeks $14bn to fight AIDS, TB and malaria pharmaceutical-technology
January 15, 2019
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to tackle these serious public health concerns.
Global Fund seeks $14bn to fight AIDS, TB and malaria pharmaceutical-technology
January 15, 2019
An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced a $14bn fundraising target for the next three years to tackle these serious public health concerns.....
RedHill Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi pharmafocusasia
December 03, 2018
RedHill Biopharma Ltd., a speciality company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal (GI) diseases...

Previous page 1 2 3 4 Next page